Fetal renal impairment

Seminars in Neonatology

Volumn 8, Issue 4, 2003, Pages 279-289

  Vanderheyden, Tina ^a   Kumar, Sailesh ^a   Fisk, Nicholas M ^a  

^a QUEEN CHARLOTTE S AND CHELSEA HOSPITAL   (United Kingdom)

Author keywords

Fetal kidney function; Fetal therapy; Fetal urine analysis; Lung hypoplasia; Maternal drug intake; Posterior urethral valves; Prenatal diagnosis; Renal agenesis; Renin angiotensin system

Indexed keywords

COCAINE; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INDOMETACIN; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; SULINDAC;

FETOSCOPY; FETUS DISEASE; HUMAN; INTRAUTERINE GROWTH RETARDATION; KIDNEY AGENESIS; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY FUNCTION; LUNG HYPOPLASIA; MULTICYSTIC DYSPLASTIC KIDNEY; NONHUMAN; OLIGOHYDRAMNIOS; PREMATURE LABOR; PRENATAL DIAGNOSIS; PRENATAL DRUG EXPOSURE; PROGNOSIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; TWIN TWIN TRANSFUSION SYNDROME; URETHRA VALVE; URINALYSIS; URINARY TRACT OBSTRUCTION; VESICOURETERAL REFLUX;

EID: 0042030801     PISSN: 10842756     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1084-2756(03)00022-8     Document Type: Article

References (81)

1. Muller F, Dommergues M, Bussieres L et al. Development of human renal function: reference intervals for 10 biochemical markers in fetal urine. Clin Chem 1996;42(11):1855-60.
2. Nicolini U, Fisk NM, Rodeck CH et al. Fetal urine biochemistry: an index of renal maturation and dysfunction. Br J Obstet Gynaecol 1992;99(1):46-50.
3. Nicolini U, Spelzini F. Invasive assessment of fetal renal abnormalities: urinalysis, fetal blood sampling and biopsy. Prenat Diagn 2001;21(11):964-9.
4. Cuckow PM, Nyirady P, Winyard PJ. Normal and abnormal development of the urogenital tract. Prenat Diagn 2001;21(11):908-16.
5. Christianson C, Huff D, McPherson E. Limb deformations in oligohydramnios sequence: effects of gestational age and duration of oligohydramnios. Am J Med Genet 1999;86(5):430-3.
6. Harrison MR, Ross N, Noall R et al. Correction of congenital hydronephrosis in utero. I. The model: fetal urethral obstruction produces hydronephrosis and pulmonary hypoplasia in fetal lambs. J Pediatr Surg 1983;18(3):247-56.
7. Laudy JA, Wladimiroff JW. The fetal lung. 1 Developmental aspects. Ultrasound Obstet Gynecol 2000;16(3):284-90.
8. Laudy JA, Wladimiroff JW. The fetal lung. 2. Pulmonary hypoplasia. Ultrasound Obstet Gynecol 2000;16(5):482-94.
9. Kilbride HW, Yeast J, Thibeault DW. Defining limits of survival: lethal pulmonary hypoplasia after midtrimester premature rupture of membranes. Am J Obstet Gynecol 1996;175(3 Pt 1):675-81.
10. Harrison MR, Golbus MS, Filly RA et al. Management of the fetus with congenital hydronephrosis. J Pediatr Surg 1982;17(6):728-42.
11. Rotschild A, Ling EW, Puterman ML et al. Neonatal outcome after prolonged preterm rupture of the membranes. Am J Obstet Gynecol 1990;162(1):46-52.
12. Atiyeh B, Husmann D, Baum M. Contralateral renal abnormalities in patients with renal agenesis and noncystic renal dysplasia. Pediatrics 1993;91(4):812-5.
13. Douglas-Denton R, Moritz KM, Bertram JF et al. Compensatory renal growth after unilateral nephrectomy in the ovine fetus. J Am Soc Nephrol 2002;13(2):406-10.
14. Hill LM, Nowak A, Hartle R et al. Fetal compensatory renal hypertrophy with a unilateral functioning kidney. Ultrasound Obstet Gynecol 2000;15(3):191-3.
15. Peters CA, Gaertner RC, Carr MC et al. Fetal compensatory renal growth due to unilateral ureteral obstruction. J Urol 1993;150(2 Pt 2):597-600.
16. Nicolaides KH, Peters MT, Vyas S et al. Relation of rate of urine production to oxygen tension in small-for-gestational-age fetuses. Am J Obstet Gynecol 1990;162(2):387-91.
17. Takeuchi H, Koyanagi T, Yoshizato T et al. Fetal urine production at different gestational ages: correlation to various compromised fetuses in utero. Early Hum Dev 1994;40(1):1-11.
18. Bassan H, Trejo LL, Kariv N et al. Experimental intrauterine growth retardation alters renal development. Pediatr Nephrol 2000;15(3-4):192-5.
19. Battista MC, Oligny LL, St-Louis J et al. Intrauterine growth restriction in rats is associated with hypertension and renal dysfunction in adulthood. Am J Physiol Endocrinol Metab 2002;283(1):E124-31.
20. Kingdom JC, Hayes M, McQueen J et al. Intrauterine growth restriction is associated with persistent juxtamedullary expression of renin in the fetal kidney. Kidney Int 1999;55(2):424-9.
21. Suranyi A, Streitman K, Pal A et al. Fetal renal artery flow and renal echogenicity in the chronically hypoxic state. Pediatr Nephrol 2000;14(5):393-9.
22. Suranyi A, Retz C, Rigo J et al. Fetal renal hyperechogenicity in intrauterine growth retardation: importance and outcome. Pediatr Nephrol 2001;16(7):575-80.
23. Oberg KC, Pestaner JP, Bielamowicz L et al. Renal tubular dysgenesis in twin-twin transfusion syndrome. Pediatr Dev Pathol 1999;2(1):25-32.
24. Mahieu-Caputo D, Dommergues M, Delezoide AL et al. Twin-to-twin transfusion syndrome. Role of the fetal renin-angiotensin system. Am J Pathol 2000;156(2):629-36.
25. Kilby MD, Platt C, Whittle MJ et al. Renin gene expression in fetal kidneys of pregnancies complicated by twin-twin transfusion syndrome. Pediatr Dev Pathol 2001;4(2):175-9.
26. Mahieu-Caputo D, Muller F, Joly D et al. Pathogenesis of twin-twin transfusion syndrome: the renin-angiotensin system hypothesis. Fetal Diagn Ther 2001;16(4):241-4.
27. Cincotta R, Oldham J, Sampson A. Antepartum and postpartum complications of twin-twin transfusion. Aust N Z J Obstet Gynaecol 1996;36(3):303-8.
28. Reisner DP, Mahony BS, Petty CN et al. Stuck twin syndrome: outcome in thirty-seven consecutive cases. Am J Obstet Gynecol 1993;169(4):991-5.
29. Barr M Jr, Sedman AB, Heidelberger KP. Renal tubular dysgenesis in twins. Pediatr Nephrol 1998;12(5):408-13.
30. Christensen AM, Daouk GH, Norling LL et al. Postnatal transient renal insufficiency in the feto-fetal transfusion syndrome. Pediatr Nephrol 1999;13(2):117-20.
31. Hilgers KF, Norwood VF, Gomez RA. Angiotensin's role in renal development. Semin Nephrol 1997;17(5):492-501.
32. Sedman AB, Kershaw DB, Bunchman TE. Recognition and management of angiotensin converting enzyme inhibitor fetopathy. Pediatr Nephrol 1995;9(3):382-5.
33. Tabacova SA, Kimmel CA. Enalapril: pharmacokinetic/ dynamic inferences for comparative developmental toxicity. A review. Reprod Toxicol 2001;15(5):467-78.
34. Buttar HS. An overview of the influence of ACE inhibitors on fetal-placental circulation and perinatal development. Mol Cell Biochem 1997;176(1-2):61-71.
35. Centers for Disease Control and Prevention. Postmarketing surveillance for angiotensin-converting enzyme inhibitor use during the first trimester of pregnancy-United States, Canada, and Israel, 1987-1995. JAMA 1997;277(15): 1193-4.
36. Norton ME, Merrill J, Cooper BA et al. Neonatal complications after the administration of indomethacin for preterm labor. N Engl J Med 1993;329(22):1602-7.
37. Khan KN, Paulson SK, Verburg KM et al. Pharmacology of cyclooxygenase-2 inhibition in the kidney. Kidney Int 2002;61(4):1210-9.
38. Peek MJ, McCarthy A, Kyle P et al. Medical amnioreduction with sulindac to reduce cord complications in monoamniotic twins. Am J Obstet Gynecol 1997;176(2):334-6.
39. Sawdy R, Lye S, Fisk N, et al. A double blind randomised study of fetal side effects during and after the short term maternal administration of indomethacin, sulindac and nimesulide for treatment of preterm labour. Am J Obstet Gynecol [in press].
40. Sawdy R, Slater D, Fisk N et al. Use of a cyclo-oxygenase type-2-selective non-steroidal anti-inflammatory agent to prevent preterm delivery. Lancet 1997;350(9073):265-6.
41. Mitra SC, Seshan SV, Salcedo JR et al. Maternal cocaine abuse and fetal renal arteries: a morphometric study. Pediatr Nephrol 2000;14(4):315-8.
42. Mitra SC, Ganesh V, Apuzzio JJ. Effect of maternal cocaine abuse on renal arterial flow and urine output of the fetus. Am J Obstet Gynecol 1994;171(6):1556-9.
43. Mitra SC. Effect of cocaine on fetal kidney and bladder function. J Matern Fetal Med 1999;8(6):262-9.
44. Reuss A, Wladimiroff JW, van der Wijngaard JA et al. Fetal renal anomalies, a diagnostic dilemma in the presence of intrauterine growth retardation and oligohydramnios. Ultrasound Med Biol 1987;13(10):619-24.
45. Fisk NM, Ronderos-Dumit D, Soliani A et al. Diagnostic and therapeutic transabdominal amnioinfusion in oligohydramnios. Obstet Gynecol 1991;78(2):270-8.
46. Sepulveda W. Stagiannis KD, Flack NJ et al. Accuracy of prenatal diagnosis of renal agenesis with color flow imaging in severe second-trimester oligohydramnios. Am J Obstet Gynecol 1995;173(6):1788-92.
47. Harrison MR, Nakayama DK, Noall R et al. Correction of congenital hydronephrosis in utero. II. Decompression reverses the effects of obstruction on the fetal lung and urinary tract. J Pediatr Surg 1982;17(6):965-74.
48. Cameron D, Lupton BA, Farquharson D et al. Amnioinfusions in renal agenesis. Obstet Gynecol 1994;83(5 Pt 2):872-6.
49. Stevens CA, McClanahan C, Steck A et al. Pulmonary hyperplasia in the Fraser cryptophthalmos syndrome. Am J Med Genet 1994;52(4):427-31.
50. Winyard P, Chitty L. Dysplastic and polycystic kidneys: diagnosis, associations and management. Prenat Diagn 2001;21(11):924-35.
51. Lazebnik N, Bellinger MF, Ferguson JE II et al. Insishts into the pathogenesis and natural history of fetuses with multicystic dysplastic kidney disease. Prenat Diagn 1999;19(5):418-23.
52. Igarashi P, Somlo S. Genetics and pathogenesis of polycystic kidney disease. J Am Soc Nephrol 2002;13(9):2384-98.
53. Friedmann W, Vogel M, Dimer JS et al. Perinatal differential diagnosis of cystic kidney disease and urinary tract obstruction: anatomic pathologic, ultrasonographic and genetic findings. Eur J Obstet Gynecol Reprod Biol 2000;89(2): 127-33.
54. Matsell DG, Mok A, Tarantal AF. Altered primate glomerular development due to in utero urinary tract obstruction. Kidney Int 2002;61(4):1263-9.
55. Herndon CD, McKenna PH, Kolon TF et al. A multicenter outcomes analysis of patients with neonatal reflux presenting with prenatal hydronephrosis. J Urol 1999;162(3 Pt 2): 1203-8.
56. Gobet R, Cisek LJ, Zotti P et al. Experimental vesicoureteral reflux in the fetus depends on bladder function and causes renal fibrosis. J Urol 1998;160(3 Pt 2):1058-62 discussion 1079.
57. Quintero RA, Homsy Y, Bornick PW et al. In-utero treatment of fetal bladder-outlet obstruction by a ureterocele. Lancet 2001;357(9272):1947-8.
58. Quintero RA, Johnson MP, Romero R et al. In-utero percutaneous cystoscopy in the management of fetal lower obstructive uropathy. Lancet 1995;346(8974):537-40.
59. Thomas DF. Prenatal diagnosis: does it alter outcome? Prenat Diagn 2001;21(11):1004-11.
60. Hutton KA, Thomas DF, Arthur RJ et al. Prenatally detected posterior urethral valves: is gestational age at detection a predictor of outcome? J Urol 1994;152(2 Pt 2):698-701.
61. Dommergues M, Muller F, Ngo S et al. Fetal serum beta2-microglobulin predicts postnatal renal function in bilateral uropathies. Kidney Int 2000;58(1):312-6.
62. Qureshi F, Jacques SM, Seifman B et al. In utero fetal urine analysis and renal histology correlate with the outcome in fetal obstructive uropathies. Fetal Diagn Ther 1996;11(5): 306-12.
63. Glick PL, Harrison MR, Golbus MS et al. Management of the fetus with congenital hydronephrosis. II: Prognostic criteria and selection for treatment. J Pediatr Surg 1985;20(4): 376-87.
64. Johnson MP, Corsi P, Bradfield W et al. Sequential urinalysis improves evaluation of fetal renal function in obstructive renopathy. Am J Obstet Gynecol 1995;173(1):59-65.
65. Lipitz S, Ryan G, Samuell C et al. Fetal urine analysis for the assessment of renal function in obstructive uropathy. Am J Obstet Gynecol 1993;168(1 Pt 1):174-9.
66. Berry SM, Lecolier B, Smith RS et al. Predictive value of fetal serum beta 2-microglobulin for neonatal renal function. Lancet 1995;345(8960):1277-8.
67. Guez S, Assael BM, Melzi ML et al. Shortcomings in predicting postnatal renal function using prenatal urine biochemistry in fetuses with congenital hydronephrosis. J Pediatr Surg 1996;31(10):1401-4.
68. Foxall PJ, Bewley S, Neild GH et al. Analysis of fetal and neonatal urine using proton nuclear magnetic resonance spectroscopy. Arch Dis Child Fetal Neonatal Ed 1995;73(3): F153-7.
69. Eugene M, Muller F, Dommergues M et al. Evaluation of postnatal renal function in fetuses with bilateral obstructive uropathies by proton nuclear magnetic resonance spectroscopy. Am J Obstet Gynecol 1994;170(2):595-602.
70. Bunduki V, Saldanha LB, Sadek L et al. Fetal renal biopsies in obstructive uropathy: feasibility and clinical correlations-preliminary results. Prenat Diagn 1998;18(2):101-9.
71. Chan FY, Borzi P, Cincotta R et al. Limb constriction as a complication of intra-uterine vesico-amniotic shunt: fetoscopic release. Fetal Diagn Ther 2002;17(5):315-20.
72. Coplen DE. Prenatal intervention for hydronephrosis. J Urol 1997;157(6):2270-7.
73. Freedman AL, Johnson MP, Smith CA et al. Long-term outcome in children after antenatal intervention for obstructive uropathies. Lancet 1999;354(9176):374-7.
74. McLorie G, Farhat W, Khoury A et al. Outcome analysis of vesicoamniotic shunting in a comprehensive population. J Urol 2001;166(3):1036-40.
75. Agarwal SK, Fisk NM. In utero therapy for lower urinary tract obstruction. Prenat Diagn 2001;21(11):970-6.
76. Welsh AW, Argawal AS, Smith RP, et al. Fetal cystoscopy in the management of fetal obstructive uropathy. Br J Obstet Gynaecol [in press].
77. Holmes N, Harrison MR, Baskin LS. Fetal surgery for posterior urethral valves: long-term postnatal outcomes. Pediatrics 2001;108(1):E7.
78. Haecker FM, Wehrmann M, Hacker HW et al. Renal dysplasia in children with posterior urethral valves: a primary or secondary malformation? Pediatr Surg Int 2002;18(2-3): 119-22.
79. Schwarz RD, Stephens FD, Cussen LJ. The pathogenesis of renal dysplasia. II. The significance of lateral and medial ectopy of the ureteric orifice. Investig Urol 1981;19(2): 97-100.
80. Schwarz RD, Stephens FD, Cussen LJ. The pathogenesis of renal dysplasia. III. Complete and incomplete urinary obstruction. Investig Urol 1981;19(2):101-3.
81. Schwarz RD, Stephens FD, Cussen LJ. The pathogenesis of renal dysplasia. I. Quantification of hypoplasia and dysplasia. Investig Urol 1981;19(2):94-6.